August 5, 2015 | The Israeli delayed release pharmaceuticals company Intec Pharma announced that it raised $27 million at a share price on $6 per share. The company raised the funds on NASDAQ at a company value of $60.6 million. Intec Pharma has developed an Accordion Pill, or medication that settles the stomach to slowly release drugs in the intestinal tract. Intec Pharma was founded in 2000 and is based in Jerusalem.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments